Group I and II introns self-splice in vitro, but require proteins for efficient splicing in vivo, to stabilize the catalytically active RNA structure. Recent studies showed that the splicing of some Neurospora crassa mitochondrial group I introns additionally requires a DEAD-box protein, CYT-19, which acts as an RNA chaperone to resolve nonnative structures formed during RNA folding. Here we show that, in Saccharomyces cerevisiae mitochondria, a related DEAD-box protein, Mss116p, is required for the efficient splicing of all group I and II introns, some RNA end-processing reactions, and translation of a subset of mRNAs, and that all these defects can be partially or completely suppressed by the expression of CYT-19. Results for the aI2 group II intron indicate that Mss116p is needed after binding the intron-encoded maturase, likely for the disruption of stable but inactive RNA structures. Our results suggest that both group I and II introns are prone to kinetic traps in RNA folding in vivo and that the splicing of both types of introns may require DEAD-box proteins that function as RNA chaperones.bakers' yeast ͉ mitochondria ͉ splicing factor D ExH͞D-box proteins are a large, ubiquitous protein family, whose members use the energy of ATP hydrolysis to mediate RNA structural rearrangements in a variety of cellular processes (1, 2). These proteins have a core region containing nine conserved motifs flanked by unique N-and͞or C-terminal extensions, which in some cases target the proteins to their sites of action by specific RNA or protein interactions. The proteins are named for the amino acid sequence of motif II, which in different subfamilies is DEAD, DEAH, or some variant thereof. Experiments with model substrates show that DExH͞D-box proteins can act as RNA helicases (3) or can disrupt ribonucleoprotein (RNP) complexes independently of their helicase activity (4). However, how these proteins function on their natural substrates has remained largely unknown.Group I and II introns self-splice in vitro but require proteins for efficient splicing in vivo to help fold the intron RNA into the catalytically active structure (5). In the fungus Neurospora crassa, the splicing of a subset of mitochondrial (mt) group I introns depends on two proteins encoded by nuclear genes, the mt tyrosyl-tRNA synthetase (CYT-18 protein), which stabilizes the catalytically active RNA structure, and the DEAD-box protein 7). Recently, CYT-19 was shown to function as an ATP-dependent RNA chaperone to destabilize nonnative structures that constitute kinetic traps in the CYT-18-assisted RNA folding pathway (7). A mutation in the cyt-19 gene did not affect the splicing of non-CYT-18-dependent group I introns or a group II intron, but did inhibit some 5Ј and 3Ј end processing reactions and, possibly, mt translation (7,8).The Saccharomyces cerevisiae nuclear genome encodes three DExH͞D-box proteins (Suv3p, Mrh4p, and Mss116p) that function in mitochondria (9-11). Of these, Mss116p is the most closely related to CYT-19. The two proteins have 32...
The Toll signaling pathway is required for the innate immune response against fungi and Gram-positive bacteria in Drosophila.Here we show that the endosomal proteins Myopic (Mop) and Hepatocyte growth factor-regulated tyrosine kinase substrate (Hrs) are required for the activation of the Toll signaling pathway. This requirement is observed in cultured cells and in flies, and epistasis experiments show that the Mop protein functions upstream of the MyD88 adaptor and the Pelle kinase. Mop and Hrs, which are critical components of the ESCRT-0 endocytosis complex, colocalize with the Toll receptor in endosomes. We conclude that endocytosis is required for the activation of the Toll signaling pathway.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.